Product image of Nitrofurantoin Eql Pharma (Nitrofurantoin) supplied by GNH India

Nitrofurantoin Eql Pharma

Active Ingredient:
Nitrofurantoin
Origin:
EU

Nitrofurantoin Eql Pharma (Nitrofurantoin)

Nitrofurantoin, the active ingredient in Nitrofurantoin Eql Pharma, is a nitrofuran antibiotic presented as an oral dosage form for oral use. It treats uncomplicated urinary tract infections in adult patients, targeting the bacteria that cause cystitis and related conditions.

GNH India supplies Nitrofurantoin Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eql Pharma Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nitrofurantoin is used to manage infections of the urinary tract by acting on susceptible bacterial pathogens.

  • Uncomplicated urinary tract infection (cystitis): eradicates causative bacteria and resolves urinary symptoms.
  • Acute uncomplicated cystitis: provides short‑course therapy to clear infection.
  • Prophylaxis of recurrent urinary tract infection: reduces recurrence when administered over a longer period.

How It Works

  • Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that damage bacterial DNA, ribosomal proteins, and enzymes involved in carbohydrate metabolism. This multi‑targeted attack disrupts essential cellular processes, leading to bacterial cell death while sparing most human cells due to limited drug activation in mammalian tissues.

Side Effects

Nitrofurantoin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Loss of appetite: reduced desire to eat.
  • Headache: transient cranial discomfort.
  • Diarrhea: loose stools, usually self‑limiting.
  • Metallic taste: persistent after‑taste in the mouth.
  • Rash: mild skin irritation or redness.

Serious or Rare Side Effects

  • Pulmonary toxicity: interstitial lung disease or acute respiratory distress.
  • Hepatic injury: elevated liver enzymes or hepatitis.
  • Hemolytic anemia: especially in patients with G6PD deficiency.
  • Severe allergic reactions: anaphylaxis or angioedema.
  • Peripheral neuropathy: tingling or numbness in extremities.
  • Blood dyscrasias: agranulocytosis or leukopenia.

Precautions & Warnings

Before prescribing Nitrofurantoin, clinicians should consider several safety factors.

  • Renal function: assess creatinine clearance; avoid if severely impaired.
  • Pregnancy: avoid unless benefits outweigh risks, especially in the first trimester.
  • Elderly patients: monitor renal function and adjust therapy as needed.
  • G6PD deficiency: contraindicated due to risk of hemolysis.
  • Concomitant medications: review for potential interactions.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Nitrofurantoin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: markedly decrease nitrofurantoin absorption.
  • Probenecid: may increase nitrofurantoin plasma concentrations.
  • Cimetidine: can raise nitrofurantoin levels, enhancing toxicity.

Moderate Interactions (Monitor Closely)

  • Warfarin: nitrofurantoin may potentiate anticoagulant effect, requiring INR monitoring.
  • Fluoroquinolones: combined use may increase risk of tendonitis or tendon rupture.
  • High‑dose vitamin C: may reduce nitrofurantoin efficacy by altering urinary pH.

Frequently Asked Questions

Nitrofurantoin Eql Pharma is an oral nitrofuran antibiotic indicated for the treatment of uncomplicated urinary tract infections, such as acute cystitis, and may also be used for prophylaxis of recurrent infections when prescribed by a qualified healthcare professional.

Nitrofurantoin is reduced by bacterial enzymes to reactive intermediates that damage bacterial DNA, ribosomal proteins, and carbohydrate‑metabolizing enzymes. This multi‑targeted attack disrupts essential bacterial processes, leading to bacterial cell death while having limited effect on human cells.

The dosage regimen for Nitrofurantoin Eql Pharma is determined by the prescribing clinician based on the patient’s condition, renal function, and other clinical factors. Patients should follow the exact dosing instructions provided by their healthcare professional.

Nitrofurantoin should be used during pregnancy only if the potential benefits justify the risks, particularly avoiding use in the first trimester and in patients with renal impairment. Limited data are available for breastfeeding; clinicians should assess risk versus benefit before prescribing.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Nitrofurantoin is distinct for its high urinary concentration and activity against many common uropathogens, including some resistant strains. Compared with trimethoprim‑sulfamethoxazole or fluoroquinolones, it has a lower risk of promoting systemic resistance but is contraindicated in patients with poor renal function.

Store Nitrofurantoin Eql Pharma below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not expose the product to excessive heat or humidity, and keep it out of reach of children.

Nitrofurantoin Eql Pharma is taken orally, usually with food or a full glass of water to improve gastrointestinal tolerance. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare provider.

Serious risks include pulmonary toxicity (interstitial lung disease), hepatic injury, hemolytic anemia in patients with G6PD deficiency, severe allergic reactions such as anaphylaxis, and peripheral neuropathy. Patients should seek immediate medical attention if they experience respiratory difficulty, jaundice, dark urine, or unexplained numbness.

Nitrofurantoin Eql Pharma is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min), known hypersensitivity to nitrofurantoin, G6PD deficiency, and in early pregnancy unless no safer alternative exists. Clinicians should evaluate each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.